Drug survival and post-drug survival of systemic treatments in a national French cohort of children with atopic dermatitis - Université de Rennes Access content directly
Journal Articles British Journal of Dermatology Year : 2020

Drug survival and post-drug survival of systemic treatments in a national French cohort of children with atopic dermatitis

E Mahé
  • Function : Author
E Puzenat
  • Function : Author
D Bessis
  • Function : Author
J Miquel
  • Function : Author
N Raison-Peyron
  • Function : Author
A Phan
  • Function : Author

Abstract

Systemic immunosuppressive treatments (IS) are restricted to severe atopic dermatitis (AD) in children. We described the IS use (first and second-line) for children with AD in a French retrospective national cohort, by using two survival analyses 'drug survival' (DS, defined as the duration of treatment) and 'post-drug survival' (PDS, defined as the time between the end of first-line and the beginning of second-line).
Fichier principal
Vignette du fichier
Chambrelan et al-Drug survival and post-drug survival of systemic treatments in a national-1.pdf (546.79 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02498639 , version 1 (25-03-2020)

Identifiers

Cite

E Chambrelan, S Barbarot, L Bekel, F Poizeau, E Mahé, et al.. Drug survival and post-drug survival of systemic treatments in a national French cohort of children with atopic dermatitis. British Journal of Dermatology, 2020, 183 (2), pp.376-378. ⟨10.1111/bjd.18941⟩. ⟨hal-02498639⟩
236 View
183 Download

Altmetric

Share

Gmail Facebook X LinkedIn More